Cessation of nilotinib in patients with chronic myelogenous...

  • Main
  • 2019 / 9
  • Cessation of nilotinib in patients with chronic myelogenous...

Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt)

Nagafuji, Koji, Matsumura, Itaru, Shimose, Takayuki, Kawaguchi, Tatsuya, Kuroda, Junya, Nakamae, Hirohisa, Miyamoto, Toshihiro, Kadowaki, Norimitsu, Ishikawa, Jun, Imamura, Yutaka, Yamazaki, Hirohito,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
International Journal of Hematology
DOI:
10.1007/s12185-019-02736-5
Date:
September, 2019
File:
PDF, 688 KB
english, 2019
Conversion to is in progress
Conversion to is failed